Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Exploring Canadian genetic healthcare providers’ perceptions on the increased availability and use of sponsored genetic testing and determining the downstream influences on laboratory resource allocation decisions within a public healthcare system

FY 2022-23

Summary
Within the Canadian healthcare system, genetic testing is publicly funded for individuals who meet provincial testing criteria and are at increased risk of having a hereditary condition. A new form of service delivery, referred to as sponsored genetic testing (SGT), occurs in partnership with biotechnology and biopharmaceutical companies to offer no-charge genetic testing to patients who meet eligibility criteria for certain conditions. In turn, the biopharmaceutical companies receive data, the data shared varies by the agreement between the biotechnology company and the testing laboratory. SGT is marketed to genetics and non-genetics practitioners; however, there is limited information regarding the potential ethical, legal, and privacy consequences which can result from the use of SGT, especially as it is often ordered by practitioners in non-genetics specialties. The aim of our research is to explore Canadian Medical Geneticist and Senior Laboratory Scientists’ perceptions on the increased use of SGT within our healthcare system. Exploring the benefits and limitations of SGT from the perspectives of Medical Geneticists and Senior Laboratory Scientists will provide an understanding on potential downstream affects on clinical management, provincial resource allocations and genetic service provisions. This information can also provide insight into gaps within current healthcare resource allocations and how that may be driving providers to order SGT. Moreover, the data generated from this project can provide a starting point for further investigations on the use of SGT within a publicly funded healthcare system.
Program
Master's Award: Canada Graduate Scholarships
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
486274
Name
Hirjikaka Daena
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring Canadian genetic healthcare providers’ perceptions on the increased availability and use of sponsored genetic testing and determining the downstream influences on laboratory resource allocation decisions within a public healthcare system
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Exploratory; Funding; Genetic Testing; Genomics; Mainstreaming; Perspectives; Policy; Providers; Resource Allocation; Sponsored
Abstract
Within the Canadian healthcare system, genetic testing is publicly funded for individuals who meet provincial testing criteria and are at increased risk of having a hereditary condition. A new form of service delivery, referred to as sponsored genetic testing (SGT), occurs in partnership with biotechnology and biopharmaceutical companies to offer no-charge genetic testing to patients who meet eligibility criteria for certain conditions. In turn, the biopharmaceutical companies receive data, the data shared varies by the agreement between the biotechnology company and the testing laboratory. SGT is marketed to genetics and non-genetics practitioners; however, there is limited information regarding the potential ethical, legal, and privacy consequences which can result from the use of SGT, especially as it is often ordered by practitioners in non-genetics specialties. The aim of our research is to explore Canadian Medical Geneticist and Senior Laboratory Scientists’ perceptions on the increased use of SGT within our healthcare system. Exploring the benefits and limitations of SGT from the perspectives of Medical Geneticists and Senior Laboratory Scientists will provide an understanding on potential downstream affects on clinical management, provincial resource allocations and genetic service provisions. This information can also provide insight into gaps within current healthcare resource allocations and how that may be driving providers to order SGT. Moreover, the data generated from this project can provide a starting point for further investigations on the use of SGT within a publicly funded healthcare system.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hirjikaka, Daena
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
University of Manitoba - $17,500 Grant (2022-23) | Canada Spends